Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abnova™ Human IGFBP1 (P08833, 218 amino acids) Partial Recombinant Protein expressed in NSO cells

Catalog No. 89948478
Click to view available options
Quantity:
25 μg

Used for Func, SDS-PAGE

This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. [provided by RefSeq]

Specifications

Accession Number P08833
For Use With (Application) Functional Study, SDS-PAGE
Formulation Lyophilized
Gene ID (Entrez) 3484
Molecular Weight (g/mol) 28.8kDa
Name IGFBP1 (Human) Recombinant Protein
Preparation Method Mammalian cell (NSO) expression system
Quantity 25 μg
Storage Requirements Store at -20°C on dry atmosphere. After reconstitution with sterilized water, store at -20°C. Aliquot to avoid repeated freezing and thawing.
Regulatory Status RUO
Endotoxin Concentration <0.1ng/μg
Gene Alias AFBP/IBP1/IGF-BP25/PP12/hIGFBP-1
Common Name IGFBP1
Gene Symbol IGFBP1
Biological Activity The ED50 as determined by its ability to inhibit IGF-I induced proliferation of NUC-1 cells is ∽100ng/mL.
Species Mouse
Recombinant Recombinant
Protein Tag None
Expression System Mammalian cell (NSO) expression system
Form Lyophilized
Purity or Quality Grade ≥98% by SDS-PAGE and HPLC
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.